VicuTec Biologicals

VicuTec Biologicals

Pre-clinical
Munich, GermanyFounded 2017vicutec.eu

Our single-domain antibodies are of superior specificity, low picomolar target-binding, and high thermal stability. They are selected by phage display from camelid immune libraries, and are suitable for large-scale production in E. coli or yeast (Pichia pastoris).

Founded
2017
Focus
AntibodiesBiologics

About

Our single-domain antibodies are of superior specificity, low picomolar target-binding, and high thermal stability. They are selected by phage display from camelid immune libraries, and are suitable for large-scale production in E. coli or yeast (Pichia pastoris).

Company Info

TypePrivate
Founded2017
LocationMunich, Germany
StagePre-clinical

Contact

SIMILAR COMPANIES
300Microns
300Microns
Pre-clinical · Munich
BetaSense
BetaSense
Pre-clinical · Berlin
AB Diagnostic Systems
AB Diagnostic Systems
Pre-clinical · Jena
bbi-biotech
bbi-biotech
Pre-clinical · Berlin
Mireca Medicines
Mireca Medicines
Pre-clinical · Munich
Is this your company?

Claim your profile to update information, add pipeline data, and connect with investors.

Claim profile